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compoundsAbstract Purpose: The objective of the present study was to design and develop stable o/w
microemulsions comprising Miglyol 812, Imwitor 988 and Tagat TO as a non ionic surfactant. This
was based on particle size measurements and phase behavior studies. The empirical role of
incorporating medium-chain mono/di-glycerides in the lipid matrix in the mechanistic processes
of emulsiﬁcation was also established in various simulating physiological conditions.
Methods: The efﬁciency of self-emulsiﬁcation was evaluated under conditions of varying key
compositions in the lipid mixtures; oil, cosurfactant and surfactant. Droplet diameter was measured
using laser diffraction and light scattering techniques. Equilibrium phase studies were performed
and phase boundaries were determined for the lipid–water systems.
Results: Microemulsion systems were produced from blends of Miglyol 812, Imwitor 988 and
Tagat TO. An optimized formulation consisted of {Miglyol 812/Imwitor 988} and Tagat TO
spontaneously self-emulsiﬁed in water producing dispersions with droplet diameters of 50 nm.
Phase equilibrium diagrams have revealed signiﬁcant enhancement in the water-solubilized region
(L2) without any presence of liquid crystalline materials.
Conclusions: Potential SMEDDS formulations for the bioavailability enhancement of poorly
water-soluble compounds were developed by mixing blends of {Miglyol 812/Imwitor 988} and
Tagat TO as a non-ionic surfactant. ‘Diffusion and stranding’ appears to be the dominant
mechanism of emulsiﬁcation.
ª 2014 Saudi Pharmaceutical Journal. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Approximately 40% of new APIs exhibit poor aqueous
solubility and present a major challenge to modern drug
delivery system because of their low bioavailability (Kyatanwar
et al., 2010). Hence, one of the most persistent challenges faced
by formulation scientists has been to ﬁnd methods to improve
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almost invariably be in solution within the gastrointestinal (GI)
tract before it can cross the GI mucosa, thus poor water solu-
bility may lead to incomplete and erratic absorption. Several
approaches are being used to overcome these challenges such
as, salt formations, micronization, solid dispersion, complexa-
tion with cyclodextrins, and incorporation of the poorly-water
soluble active component into inert lipid vehicles such as
oils, surfactant dispersions, self-emulsifying formulations and
liposomes (Stegemanna et al., 2007).
Nonetheless, Lipid based technology as an approach to en-
hance the bioavailability of poorly water soluble compounds
for oral application has received great attention by formula-
tion scientists and hence, witnessed the introduction of success-
ful products on the market including Neoral (Cyclsoprin A,
Novartis) (Murdandea and Gumkowskia, 2008), Kaletra
(Lopinavir and Ritonavir, Abbott) (Lugt et al., 2009), Forto-
vase (Saquinavir, Roche) (Grovea and Mullertzb, 2006),
however, in 2006 Fortovase was removed from the market
due to lack of demand (Wadhwa et al., 2012), Targretin (Bex-
arotene, Ligand) (Chen et al., 2013), Agenerase (Amprenavir,
GlaxoSmithKline) (Suman et al., 2009), Lipirex (Fenoﬁbrate,
Sanoﬁ-Aventis) (Singh et al., 2009), Rocaltrol (Calcitriol,
Roche) (Kubisaa et al., 2012) and Avodart (Dutasteride,
GlaxoSmithKline) (Choo et al., 2013)
Self-emulsifying drug delivery systems (SEDDS) are isotro-
pic mixtures of oils and non-ionic surfactants which spontane-
ously emulsify in water upon gentle agitation producing ﬁne
oil in water (o/w) dispersions of droplets <5 lm (Shah
et al., 1994). On the other hand, self-micro-emulsifying drug
delivery system (SMEDDS) is the name given to a drug vehicle
consisting of oil or modiﬁed oils, surfactant and co-surfactant
mixtures, solid or liquid at ambient temperature, which emul-
siﬁes spontaneously when mixed with water under gentle agita-
tion forming a o/w microemulsion of droplets with diameters
between 5 and 140 nm (Farah et al., 1993). Both SEDDS
and SMEDDS can provide a reservoir of drug dissolved in
the lipid matrix, which upon administration and making con-
tact with gastrointestinal ﬂuids spontaneously emulsify pro-
ducing oil-in-water dispersions of small particle size with
large surface area available for drug diffusion (Hasan, 2004).
Thus, lipid based formulations represent an efﬁcient vehicle
for the in vivo administration of oral delivery of lipophilicTable 1 Typical properties of Type l, ll, lll and IV lipid formulatio
Increasing hydrophilic content ﬁ
Type I Type II
Typical composition (%)
Triglycerides or 100 40–80
Mixed glycerides
Surfactants 0 20–60 (HLB<
Hydrophilic cosolvents 0 0
Particle size of
dispersion (nm)
Coarse 100–250
Signiﬁcance of
aqueous dilution
Limited importance Solvent capac
unaﬀected
Signiﬁcance of
digestibility
Crucial requirement Not crucial bu
likely to occurdrugs, with a possible alternative to tablets and capsules,
provided however, that the drug has adequate solubility in
the oil system.
However, In order to facilitate the prospect of formulation
design using lipid based technology, lipid systems were classi-
ﬁed by Pouton (2000, 2006) into Type I, II, III and IV based
on various physicochemical factors such as, the hydrophilicity
of the oil mixture, particle size of the resultant dispersion and
the formulation digestibility (Table 1).
The lipid class system by Pouton (2006) has prompted the
investigation of how key elements in the oil composite can
inﬂuence the behavior of these systems and hence impact on
the physical state of the drug after dispersion. Among these
factors are included, type of oil, the use of co-surfactants,
oil/co-surfactant ratio, the HLB of the surfactant and the
inclusion of hydrophilic cosolvents (Hasan, 2004). Type I for-
mulations comprise drug in solution in triglycerides and/ or
mixed glycerides. Type II lipid formulations are deﬁned as
self-emulsifying formulations that consist of water insoluble
components; the drug is dissolved in triglycerides and/ or
mixed glycerides blended with non-ionic surfactants of HLB
between 10 and 12. Type III systems are also called self-micro-
emulsifying systems, as optical clarity can be achieved with
these formulations. These systems besides triglycerides and/
or mixed glycerides contain hydrophilic components including
hydrophilic nonionic surfactants (HLB > 12) and or hydro-
philic co-solvents. Type III formulations are further sub-classi-
ﬁed into Type IIIA and Type IIIB addressing the degree of
hydrophilicity of this type. This renders Type IIIB relatively
more hydrophilic than Type I, Type II or Type IIIA, which
is likely to result in a colloidal solution of drug and oil in aque-
ous micelles and hence presents high risk of drug precipitation.
Type IV formulations do not contain natural lipids and repre-
sent the most hydrophilic formulations.
An archetypal example of a Type III system is the reformu-
lation of cyclosporine A as Neoral (Pouton, 1999) (Table 2).
The drug was more available from the Neoral than the earlier
‘Sandimmune’ formulation, which was a coarsely emulsifying
system (Muller et al., 1994). This might be due to the fact that
the coarse emulsion produced by the Sandimmune formulation
could not be reduced to colloidal dimensions because of lim-
ited digestion (Pouton, 2000). An example of a Type IV formu-
lation is the current capsule formulation of the HIV proteasens (Pouton, 2006).
Type IIIA Type IIIB Type IV
40–80 <20 0
12) 20–40 (HLB>12) 20–50 (HLB>12) 0–20 (HLB<12)
20–80 (HLB>12)
0–40 20–50 0–80
100–250 50–100 <50
ity Some loss of
solvent capacity
Signiﬁcant phase
changes and
potential loss of
solvent capacity
Signiﬁcant phase
changes and potential
loss of solvent capacity
t Not crucial but
may be inhibited
Not required and
unlikely to happen
Not required and
unlikely to happen
Table 2 Composition of Neoral compared with Sandimunn (Lawrence, 1996).
Neoral Amount (mg) Sandimunn Amount (mg)
Cyclosporin 100 Cyclosporin 100
1,2 propylene glycol 75 Ethanol 100
Ethanol 150 Maize oil 416
Partial glycerol transesteriﬁed
corn oil
345 Transesteriﬁed triglyceride and
Polyalkaline polyol (Labraﬁl M2126)
300
Cremophor RH 40 405
Total amount per dose 1075 Total amount per dose 916
582 N.M.Y. Hasaninhibitor amprenavir (Agenerase) which contains TPGS as a
surfactant and PEG 400 and propylene glycol as co-solvents
(Suman et al., 2009).
This investigation focuses on the role of medium-chain
mono/diglycerides in aiding the emulsiﬁcation of lipid mixtures
by conducting phase behavior studies to establish the mecha-
nistic processes involved. It is also designed to elucidate the ef-
fects of mixture composition, emulsiﬁcation temperature and
media on the emulsiﬁcation performance. As a result, potential
self-microemulsifying formulations representing Type II sys-
tems composed of water dispersable materials have been devel-
oped to improve the bioavailability of poorly water-soluble
compounds.
2. Materials and methods
2.1. Materials
Miglyol 812 (medium chain triglyceride) and Imwitor 988 (C8/
C10 mono/diglycerides) were supplied by Condea Chemie
GmbH. Tagat TO (PEG-(25)-glyceryl trioleate) was supplied
by Goldschmidt AG, Germany. The fatty acid distribution in
Miglyol 812 according to the manufacturer is: caprylic (C8):
50–65%, capric (C10): 30–45%, caproic (C6): <2% and Lauric
acid C12: <3%. Imwitor 988 is approximately a 1:1 mixture of
C8/C10 mono/diglycerides with 2% free glycerol. Tagat TO is
an ethoxylated triglyceride of commercial oleic acid; 65% oleic
with the remainder mainly myristic C14, palmitic C16, stearic
C18, and linoleic C18: 2. Simulated Gastric Fluid (SGF) without
pepcin; 2.4 g NaCl and 7 ml HCl/1000 ml water, supplied by
Sigma. All water used was Mili Q water.
2.2. Methods
2.2.1. Self-emulsiﬁcation
Mixtures of oil and surfactant were produced by accurately
weighing ingredients into screw-capped glass vials with tight
closures followed by vortexing. Various oil blends of {Miglyol
812/Imwitor 988} were mixed with increasing concentrations
of Tagat TO. An amount of 1gm of each mixture was intro-
duced into 100 ml of Mili Q water in a 500-ml glass beaker
held at 37 C in a thermostatically controlled water bath. All
materials were pre-equilibrated to the appropriate tempera-
ture. Agitation was provided by gentle shaking on a mechani-
cal shaker at 100 oscillation per min.
2.2.2. Analysis of mean emulsion droplet diameter (MEDD)
Two techniques were used to measure the MEDD of the self-
emulsiﬁed systems (with appropriate dilution). Low angle laserlight diffraction (Malvern Mastersizer X) with small volume
cell using 45 mm lens was used for emulsions with droplet
distributions above 1 lm. Quasi-elastic light scattering (QELS,
Malvern model LO-C photon correlation spectrometer) was
used to analyze samples of submicron dispersions. For both
techniques experiments were performed in triplicate and the
size distributions of the resultant emulsions were obtained
using the volume-average diameters of the 50 percentiles, D
(v, 0.5). MEDD values are expressed as mean values of all
data ± standard error.
2.2.3. Equilibrium phase studies
Phase behavior studies were conducted by twomethods in order
to construct pseudo-ternary and binary phase diagrams. (1)
Static composition method: A series of phase compositions of
oil, surfactant andwater of 5 gmixtures weremade up byweight
in screw-capped glass vials. For construction of the whole ter-
nary phase diagram, phase composition changes were made at
5%w/w intervals. Additional compositions were made at
2.5%w/w intervals where phase boundaries were observed.
The various ternary and binary compositions were heated to
70 C in a thermostatically controlled water bath for 15 min
with intermittent mixing using a Fisons orbital vortex mixer un-
til homogeneity was achieved. The mixtures were then allowed
to cool to 25 C and left undisturbed for 24 h for phase identiﬁ-
cation by visual observation using a crossed polarized viewer.
(2) Dynamic composition method: For this method the weighed
amounts and therefore the ratios of oil and nonionic surfactant
in each mixture were constant, the only difference is the water
content. Phase studies were performed using 2 g samples of
oil-surfactant mixtures diluted sequentially by the weighed
addition of water. Formulations of interest were weighed into
narrow bore glass ampoules. Milli-Q water was then sequen-
tially added to the oil mixtures at 0.5%w/w intervals, ampoules
were then sealed using an Adelphi ampoule sealer. The am-
poules were then heated to 70 C for 15 min to facilitate mixing
using a vortexer. The ternary mixtures were equilibrated to the
temperature of interest (4–65 ± 0.1 C) for two hours and then
thoroughly mixed for 5 min using a Fisons orbital whirlmixer.
The ampoules were then returned to the thermostatically con-
trolled water bath and left undisturbed for 24 h before identiﬁ-
cation of the phase type using a crossed polarized viewer.
2.2.4. Effect of emulsiﬁcation temperature
Emulsions formed by mixtures of Miglyol 812/Imwitor 988
(10:0, 7:3, 6:4 and 5:5) containing 15% or 30%w/w Tagat
TO were investigated over a temperature range between 5
and 60 C. Emulsions were prepared under conditions of gen-
tle agitation at the required temperature as described earlier.
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at 25 C in thermostatted water bath before particle sizing.
2.2.5. Effect of SGF on emulsiﬁcation
Self-emulsiﬁable mixtures (1 g) of different oil systems were
introduced into 100 ml of SGF in a 500-ml glass beaker held
at 37 C in a thermostated water bath and emulsiﬁed for
15 min as described earlier before particle sizing.3. Results and discussion
3.1. Particle size analysis
Previous studies using binary systems containing medium-
chain triglyceride oil (Miglyol 812) and Tagat TO have pro-
duced systems that exhibit optimum self-emulsifying behavior
at 30 C (Pouton et al., 1987; Wakerly et al., 1986). In contrast
to the Tween 85-Miglyol 812 investigated by Pouton (1985), the
Tagat TO-Miglyol 812 system produced by Wakerly et al.
(1986), was shown to be capable of forming submicron emul-
sions by self-emulsiﬁcation. In this study, the effect of incorpo-
rating, C8/C10 mono/diglycerides (Imwitor 988) in the binary
mixtures of Miglyol 812/Tagat TO on emulsiﬁcation behavior
has been investigated to establish the optimum requirements
for good self-emulsifying systems. Imwitor 988 was included
in the binary system (Miglyol 812/Tagat TO) by varying the ra-
tio fraction of Miglyol 812/Imwitor 988 while gradually
increasing the concentration of Tagat TO in each ratio.
The emulsiﬁcation proﬁle of Miglyol 812/Tagat TO system
was chosen as the starting point to compare the emulsiﬁcation
behavior that results from the inclusion of Imwitor 988 in the
binary mixtures. The particle size-surfactant concentration
proﬁles obtained by laser diffraction analysis for the self-emul-
siﬁed Miglyol 812/Imwitor 988-Tagat TO mixtures are shown
in Fig. 1. The self-emulsiﬁcation proﬁle of Miglyol 812/TagatMixture compositio
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Figure 1 Mean emulsion droplet diameter (MEDD) proﬁles for se
Imwitor 988 and increasing concentrations of Tagat TO. Lipid formula
were determined by laser diffraction method using the Mastersizer. Ba
of oil systems containing Miglyol/Imwitor ratios of 7:3 or 6:4 at Tagat T
due to the size range cut off of the apparatus.TO presents three regions: (1) Low surfactant concentrations
<15% (w/w) gave rise to a region of gross instability with high
creaming rate. Microscopical examination of these crude emul-
sions showed that oil droplets in excess of 500 lm were present
(Wakerly et al., 1986). (2) Concentration of surfactant between
20% and 45% resulted in sub-micron emulsions of improved
stability. The MEDD apparently reached a minimum value
at surfactant concentrations of 40–45%. The reduction in the
MEDD in this second region probably resulted from increased
interfacial stabilization by water soluble surface active compo-
nents as the surfactant concentration was increased. (3) At
higher surfactant concentrations (>50%) the MEDD in-
creased with a doubling of the polydispersity. The turbidity
of self-emulsiﬁed systems decreased as the surfactant concen-
tration was increased from 45% to 60%. The increase in the
MEDD values for optically clear systems containing more
than 45% surfactant may be explained by the large swollen
microemulsion systems described by Gerbacia and Rosano
(1973), where the refractive indices of dispersed and continu-
ous phases are very similar.
The progressive inclusion of Imwitor 988 at 65 parts in the
oil blend (Miglyol 812/Imwitor 988 at ratios of 9:1, 7:3, 6:4 and
5:5) has improved the emulsiﬁcation proﬁles with respect to the
Miglyol 812/Tagat TO system as, relatively lower MEDD val-
ues were obtained at almost all surfactant concentrations
(Fig. 1). On the other hand, less self-emulsiﬁable mixtures pre-
sented by an increase in the MEDD values with reference to
Miglyol 812/Tagat TO were produced when Imwitor was in-
cluded in the oil blend at >5 parts (Miglyol 812/Imwitor
988 at ratios of 3:7, 1:9 and 0:10). Optimum dispersions of near
optical clarity which were classiﬁed as self-micro-emulsifying
systems were obtained at Miglyol 812/Imwitor 988 ratios of
7:3 or 6:4 at Tagat TO concentrations between 30% and
40%w/w. These formulations were at the lower detection limit
of the Mastersizer at surfactant concentration above 20% as
they formed typical bluish clear microemulsions. Therefore,n (%w/w Tagat TO)
40 50 60 70
Miglyol
Miglyol/Imwitor 9:1
Miglyol/Imwitor 7:3
Miglyol/Imwitor 6:4
Miglyol/Imwitor 5:5
Miglyol/Imwitor 3:7
Miglyol/Imwitor 1:9
Imwitor
lf-emulsiﬁed systems containing different ratios of Miglyol 812/
tions were emulsiﬁed in water at 37 C for 15 min. MEDD values
rs Represent Standard Errors (n= 3). Size droplets of dispersions
O concentrations >20% could not analyzed using the Mastersizer
584 N.M.Y. Hasanthese systems were further characterized using PCS technique.
Results obtained from PCS for emulsions formed from
Miglyol 812/Tagat TO and {Miglyol 812/Imwitor} (6:4 or
7:3)-Tagat TO systems are shown in Fig. 2. Self-emulsifying
mixtures of Miglyol 812/Tagat TO, produced a minimum
MEDD of 220 nm at surfactant concentration between
25% and 30%. At surfactant concentrations between 20%
and 40% for Miglyol 812-Tagat TO system, MEDD values
measured by PCS method were lower than expected from the
laser diffraction analysis using the Mastersizer. This may have
been due to underestimation by PCS of the MEDD of this sys-
tem which probably contained droplets >3 lm, which would
have been excluded from any PCS analysis. Emulsions formed
by Miglyol 812/Tagat TO mixtures containing, however, less
than 20% surfactant were poor and therefore, was not possible
to detect any scattered light using the PCS at the normal sen-
sitivity level i.e. the MEDD of such emulsions were always out
of the range covered by the apparatus.
As Fig. 2 depicts, the particle size-surfactant concentration
proﬁles for {Miglyol 812/Imwitor} at ratios of 7:3 or 6:4 are of
similar character exhibiting a minimum MEDD of 50 to
60 nm at about 30–40% Tagat TO. Nonetheless, At surfactant
concentrations >45% both systems 7:3 and 6:4 have produced
though clear dispersions, yet, MEDD values have dramatically
increased with a doubling of the polydispersity. This could be
attributed to the formation of swollen microemulsion systems.
Therefore, as Fig. 2 illustrates, the inclusion of only 30%w/w
Imwitor 988 in the oil blend has signiﬁcantly reduced the oil
droplet size and resulted in producing self-micro-emulsifying
system. This is evident from the contour plot representation
of MEDD data depicted in Fig. 3 whereby, progressive inclu-
sion of Imwitor 988 in the lipid mixture had caused a corre-
sponding reduction in the oil droplet size of resultant
dispersions. This was, however, up to a point where, further
incorporation of Imwitor 988 caused increases in MEDD val-
ues. It is thought that Imwitor 988 which acts here as a co-sur-
factant can stabilize the interface by penetrating into the void
spaces among surfactant molecules in the surfactant ﬁlmMixure compositio
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Figure 2 Mean emulsion droplet diameter proﬁles for Miglyol 812
systems at increasing surfactant concentration. Oil formulations we
measured by photon correlation spectrometer (PCS). Bars represent saround the oil droplet and hence lowering the interfacial ten-
sion and increasing the interfacial ﬂuidity. At optimum con-
centrations of co-surfactant in the oil mixture, saturation at
the O/W interface is achieved which results in producing lower
particle size proﬁles. On including yet more cosurfactant in the
system, the excess will disperse in the aqueous phase and as it
has limited solubility in water, at this point particle size of the
resultant dispersion is increased.
The signiﬁcance of this robust self-microemulsyfying lipid
system (Miglyol 812/Imwitor 988-Tagat TO at ratios of
70(70/30)30) is the ability to retain its solvent capacity for
the drug after dispersion. This is due to it being comprised
of water in-soluble components. Furthermore, this system is
expected to have better solubilizing capacity for poorly-water
soluble drugs as Imwitor 988 is apolar oil due to its monoglyc-
eride content.
Medium-chain (C6–C12) fatty acids, mono-, di-, and tri-gly-
cerides, particularly C8/C10 mono/diglycerides, have been used
in mixed micelle and emulsion formulations as absorption
enhancers of a number of different drugs (Muranishi, 1990).
In this investigation Imwitor 988 acts as a co-surfactant with
a similar effect to short chain alcohols in aiding the emulsiﬁca-
tion process of oil based formulations.
3.2. Phase behavior: mechanistics of self-emulsiﬁcation
Although self-emulsiﬁcation is a dynamic non-equilibrium
process involving interfacial phenomena, information about
the self-emulsiﬁcation can be obtained using investigations of
equilibrium phase behavior (Charman et al., 1992). Emulsiﬁca-
tion efﬁciency of oil-surfactant systems (as determined from
particle size) has been characterized and correlated with equi-
librium phase diagrams.
Wakerly (1989) studied binary mixtures of Miglyol 812-
Tagat TO in an attempt to elucidate the mechanistic processes
of emulsiﬁcation and to highlight the important involvement
of liquid crystalline phases forming at the interface in such
processes. Therefore, the initial work described here wasn (%w/w Tagat TO)
40 50 60 70
Miglyol
Miglyol/Imwitor 7:3
Miglyol/Imwitor 6:4
/Tagat TO and {Miglyol 812/Imwitor 988} (6:4, 7:3)-Tagat TO
re emulsiﬁed in water at 37 C for 15 min. MEDD values were
tandard errors (n= 3).
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Figure 3 Contour plot representation of mean emulsion droplet size data (nm) for the emulsiﬁcation of Miglyol 812/Imwitor 988-Tagat
TO system. Optimum values were obtained at 30%w/w Imwitor 988 in the oil blend.
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system as described by Wakerly. Hence, the effects of incorpo-
rating Imwitor 988 on the efﬁciency of emulsiﬁcation of the
binary mixtures will be established using equilibrium phase
diagrams. Equilibrium phase behavior was studied in two ways
(1) Static composition dilution method and (2) Dynamic
composition dilution method.0
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586 N.M.Y. Hasantransparent liquid crystalline dispersion exhibited low viscosity
and ‘‘multicoloured’’ birefringence, typical of lamellar liquid
crystalline phases. The presence of signiﬁcant quantities of
liquid crystalline material was established by strong
birefringent patterns observed using the polarizing viewer.
3.2.1. Equilibrium phase behavior using static compositions
The triangular equilibrium phase diagram for the Miglyol 812-
Tagat TO-water system at 25 C is shown in Fig. 4. For sim-
plicity no differentiation was made between the different liquid
crystal phases in the initial equilibrium phase diagram studies.
Considering the dilution of Miglyol 812/Tagat TO (70/30) with
water at 25 C, as depicted by the line B–A, the initial binary
mixture (L2 phase) could pass through L2ﬁ LCﬁ L1 +
L2 + LCﬁ L1 + L2 phases. However, during self-emulsiﬁca-
tion of the binary mixture non-equilibrium multiple phases
could have been formed. Therefore, the complete route de-
picted by line B–A may not be followed. As Fig. 4 depicts,
maximum solubilization of water (L2) of only 10% was ob-
served. In his study Wakerly [9] by constructing the triangular
equilibrium phase diagrams for the Tagat-Miglyol-water sys-
tem at various temperatures, 25, 30 and 40 C, concluded that,
the presence of a L1 + L2 + LC region which only occurred to
a great extent at 25 C is not essential for self-emulsiﬁcation. It
is thought that the LC phase adjacent to the isotropic L2
region probably controls self-emulsiﬁcation.
The triangular phase diagram for {Miglyol 812/Imwitor
988} (7:3)-Tagat TO-water system is depicted in Fig. 5. Lines
B–A and C–A represent the dilution with water of {Miglyol
812/Imwitor 988} (7:3) at Tagat TO ratios of 30 or 40, respec-
tively. This region on the phase diagram, with respect to the
Miglyol 812-Tagat TO-Water system, has shown signiﬁcant
enhancement in the L2 region, and the complete routes of lines
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bilization of water as L2 phase of around 40% or 50% was ob-
served for oil mixture at ratios of 70(70/30)30 or 70(70/30)40,
respectively (lines B–A and C–A depicted in Fig. 5). This indi-
cates the fact that the enhancement in the L2 region is of par-
amount importance in the mechanistics of emulsiﬁcation when
Imwitor 988 is included in the system, as the region is clear
from any presence of LC phases. It is worth noting here that
phase behavior studies for lipid mixtures containing > 30%
of Imwitor 988 in the oil blind have shown relative reduction
in the L2 region (data not shown). This correlates well with
the particle size data whereby, 30% of Imwitor 988 in the oil
blend is the optimum ratio for self-microemulsiﬁaction.
3.2.2. Equilibrium phase behavior using dynamic compositions
In order to highlight the important detailed areas on the phase
diagrams in the region 0–40%w/w of water which appear to be
crucial for the emulsiﬁcation process, equilibrium phase dia-
grams with respect to water content and temperature described
by Shinoda and Friberg (1986) were constructed. Comparative
equilibrium phase studies were carried out on Miglyol-Tagat
TO system with and without Imwitor 988. This enables insight
into the mechanistics of the observed changes in self-emulsiﬁ-
cation behavior of these systems.
Fig. 6a displays the equilibrium phase diagram for a system
containing 70% (w/w) Miglyol 812 and 30%w/w Tagat TO on
dilution with water. Maximum water solubilization (L2) ex-
tended to 7% at 45 C. Moreover, large area of liquid crystalOil
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Figure 7 Mechanistics of self-emulsiﬁcation process for (a) systems
system); this process involves the formation of liquid crystalline phase
component, e.g. {Miglyol 812/Imwitor 988}-Tagat TO system; ‘diffusio
for these systems which can lead to very ﬁne dispersions.phase (LCa and L2 + LCa) occurred on further dilution with
water between 6 and 10%w/w at temperatures below 50. On
the other hand, by incorporating three parts of Imwitor 988
in the binary mixture, as shown in Fig. 6b, substantial exten-
sion in the L2 region occurred reaching a maximum of almost
33%w/w water at 20 C and with no sign of LC phases. This is
reﬂected in the ﬁne dispersion obtained from the emulsiﬁcation
data of this system.
As depicted in these phase studies, there are two distinctive
features that may correlate to the efﬁciency of emulsiﬁcation;
(a) a region of enhanced water solubilization typical of non-
ionic surfactant systems and thought to be a phase inversion
region (b) the formation of a lamellar liquid crystalline disper-
sion phase on further incorporation of water (Fig. 7a). The
occurrence of such stable or metastable liquid crystal disper-
sions at the oil–water interface, based on loosely associated
aggregation structures was suggested to allow rapid penetra-
tion of water and disruption of the interface (Pouton, 1982).
The resulting disruption will promote rapid self-emulsiﬁcation.
The inclusion of Imwitor 988 in the binary mixtures (Mi-
glyol-Tagat TO) has substantially transformed the phase
behavior of these oil systems. It has induced three major
changes in the phase diagram structure of the binary mixtures,
as summarized in Table 3. Firstly; changes in the L2 region;
progressive inclusion of Imwitor 988 has resulted in extensive
enhancement in the water soubilisation region; including Imw-
itor 988 in the oil blend at ratios between 0%w/w and 30%w/w,
extended the L2 region from 7% to 32%. According to criteriail-rich
a phase
Water
Oil droplets ejected
from the interface
of mutual 
ytilib Oil nucleation as 
solvent capacity is lost
Water
Hydrophilic
components
nt.
E
containing water-insoluble materials (e.g. Miglyol 812/Tagat TO
s at the oil–water interface (b) systems containing a water-soluble
n and stranding’ is thought to be the mechanism of emulsiﬁcation
Table 3 Summary of the changes in the phase behavior resulted from including various proportions of Imwitor 988 in the binary
mixture of Miglyol 812/Tagat TO (70/30). L2: oil-based liquids; LCa: liquid crystalline phases; PBT: phase boundary temperature.
Description of phase Behavior Wt% ratio of Imwitor 988 to Miglyol 812 included in the lipid mixture
0 10 30
L2 max. (%) 7 12 32
LCa +++ ++ –
Gel phase – – +
PBT (C) 45 30 20
Particle size (nm) 221.80 202.40 49.5
588 N.M.Y. Hasanfor the identiﬁcation of microemulsions, L2 phase in aqueous
systems of polar lipids and triglyceride oil is w/o microemul-
sion. On the basis of an X-ray study obtained by cooling L2
phases (Fontell et al., 1983), it was proposed that the structure
consists of water lamellae separated by lipid bilayers corre-
sponding to liquid–crystalline phase. Secondly; changes in the
Phase Boundary Temperatures (PBT) which is referred to here
as the minimum temperature at which phase transition from
L2/LC phase boundary to L1 + L2 occurs. This phase bound-
ary temperature has a signiﬁcant role which underlines the
phase inversion temperature (PIT). It was evident from the
phase behavior study that the inclusion of Imwitor 988 in the
lipid mixture resulted in depression of the PBT; including Imw-
itor 988 in the oil blend at ratios between 0% and 30% caused
depressions in the PBT from 45 to 20 (C). This could be attrib-
uted to the fact that Imwitor 988 as a polar oil increases the sol-
ubility of the surfactant in the oil phase thus, less temperature is
needed to exert phase inversion in the system. Thirdly; disap-
pearance of liquid crystalline materials and the formation of
gel phase instead, which was only observed when the ratio of
Imwitor 988 in the oil blend exceeded 30%.
Based on a study byRang andMillar (1998, 1999) investigat-
ing the emulsiﬁcation of oils containing hydrocarbon, nonionic
surfactant and n-octanol, the following mechanism for the self-
emulsiﬁcation of Miglyol 812-Imwitor 988-Tagat TO system
can be proposed, see Fig. 7b. Addition of the oil mixture to
water results in the formation of interface between the oil and
aqueous-continuous phases. Solubilization of water with the
oily phase results from aqueous penetration through the inter-
face. This will occur until maximum solubilization (L2) is
reached close to the interface. Further aqueous penetration re-
sults in diffusion of the polar component of Imwitor 988 (1-
Monocaprylate) and also to some extent Tagat TO into water.
Subsequently, the system becomes supersaturated in oil and
thus spontaneous nucleation of small oil droplets from the
microemulsion occurs (i.e. phase transition from L2 to
L1 + L2). Further diffusion of Tagat TO and monocaprylate
out of the L2 phase forms a system that is ever more hydrophilic
so that it eventually becomes miscible with water. The particle
size of the nucleated oil droplets formed due to the diffusion
process is expected to be related mainly to the interfacial and
rheological properties of the L2 phase; the larger the (L2) area
in the phase diagram the smaller the size of the nucleated oil
droplets and vice versa. Optimal range of initial drop composi-
tions is required to obtain an emulsion of small oil droplets.
According to our ﬁndings spontaneous micro-emulsiﬁcation
yielding uniformly ﬁne dispersions was achieved when the intro-
duced drop was slightly lipophilic; i.e. (i) the ratio of Miglyol
812 to Imwitor 988 was slightly greater than that of the excess
oil phase in equilibrium with a bicontinuous microemulsion atthe experimental temperature, and (ii) when sufﬁcient Tagat
TO was used. The need for this slightly lipophilic oil
composition is attributed to the relatively low HLB value of
Tagat TO (HLB  11). However, in the case of surfactants
with higher HLB values, less lipophilic oil composition is
required.3.3. The effect of emulsifying temperature and medium self-
emulsiﬁcation
3.3.1. Temperature variation
It is important from the stability prospective in emulsions to
investigate the optimum temperature for stable emulsiﬁcations,
the optimum hydrophilic chain length and the phase inversion
temperature (PIT) of emulsiﬁers. Non-ionic surfactants often
become increasingly more lipophilic at elevated temperatures.
The change in micellar shape, size and eventual loss of aqueous
solubility with increase in temperature is due to decreased
hydration of the surfactant. Hydrogen bonding forces, which
account for aqueous solubility, are reduced at elevated temper-
atures. This is analogous to reducing the HLB of the surfactant.
The change in nonionic surfactant-oil–water system (nSOW)
phase behavior with temperature can result in the phase transi-
tionsWinsor’s type I to type III to type II. Therefore, the higher
the emulsiﬁcation temperature is than the PIT of the emulsiﬁer,
the larger the emulsion droplets will be. Emulsiﬁcation at tem-
peratures slightly below the PIT (about 2–4 C below) affords
optimum oil droplets of an o/w-emulsion type.
As Imwitor 988 is a polar oil that causes depressions in PIT
which means that emulsion type inversion from o/w to o/w oc-
curs at lower temperatures causing growth in oil droplet size.
This action, however, is concentration dependent and more-
over, is highly likely to be averted by using surfactants with rel-
atively high HLB values (>12). Tagat TO has an HLB of 11
and hence, any reduction of its hydrophilicity due to tempera-
ture or electrolytes in the media will affect the emulsiﬁcation
performance of the lipid mixture. Nonetheless, oil systems con-
taining 30% Tagat TO have shown no large increase in the
MEDD at high emulsiﬁcation temperatures comparable to
the particle size increase observed when these systems con-
tained 15% surfactant. For {Miglyol 812/Imwitor 988}-Tagat
TO at ratios of 70{70/30}30, almost clear microemulsion dis-
persions of minimum particle size around 50 nm were pro-
duced at temperatures between 35 and 40 C. Dispersions
turned turbid at temperatures above 45 C and yet, on cooling
to the room temperature for size measurement they became
clear again. This phenomenon has been observed by many
researchers and considered to be one of the distinctive criteria
for microemulsions.
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Since the luminal environment in the proximal GI tract varies
considerably with site and meal ingestion, it is essential to
consider the use of several different sets of emulsiﬁcation con-
ditions to assess the dissolution behavior of the oil formulations
with and without drugs. The United States Pharmacopoeia
(1995) calls for the Simulated Gastric Fluid (SGF) to simulate
dissolution in the stomach. SGF simulates pH conditions in
the fasted stomach. In the fed state, however, composition in
the stomach will be highly dependent on the ingested meal.
Long-life milk (Macheras et al., 1986) and clinical nutrition
products, e.g. Ensure HN (Ashby et al., 1989) have been
suggested as media suitable for simulating fed state in the
stomach.
Generally, electrolytes present in the emulsiﬁcation media,
as the variation in temperature, can affect the emulsiﬁcation
performance of lipid formulations. Due to salting out effect
the preferential aqueous solubility of the surfactant is shifted
to the oil phase inducing phase separation. This effect, how-
ever, can be counteracted by using surfactants with relatively
high HLB values, as any reduction of the surfactant hydrophi-
licity incurred by electrolytes will not be sufﬁcient to induce
phase separation.
A signiﬁcant increase in the MEDD values was observed
for lipid mixtures containing >20% of Imwitor 988 after
emulsiﬁcation in SGF versus water. Lipid mixtures compris-
ing {Miglyol 812/Imwitor 988}-Tagat TO at ratios of
70{70/30}30 produced dispersions of oil droplet size of
150 nm on emulsiﬁcation in SGF vis-a`-vis 50 nm in water.
This almost threefold increase in the MEDD value can be ex-
plained by the effect of Imwitor 988 on reducing the PIT and
also the loss of surfactant’s afﬁnity for the aqueous phase be-
cause of the electrolytes present in the media. This may sug-
gest a phase inversion at temperatures lower than the
preferable optimum temperature for emulsiﬁcation (37 C).
For use in vivo it would obviously be preferable to have opti-
mum emulsiﬁcation at 37 C yet this might be achieved by
using slightly more hydrophilic surfactants such as, Cremo-
phor RH 40 and Tween 80. Nonetheless, this does not pre-
clude the use of this system in vivo since particles around
150 nm are still achievable. This increase in the oil droplet
size may minimize the effect of water in ‘squeezing out’ the
drug, if it is to be delivered with this system, by minimizing
the direct contact with the aqueous phase. In this case, the
drug will be sequestered within the oil phase and hence, crys-
tallization is prevented. Furthermore, it is worth noting that
in vitro emulsiﬁcation using SGF does not bring about a full
picture of what is going on in the stomach. Hence the media
excludes the human gastric lipase which initiates gastric lipol-
ysis; a process that aids the emulsiﬁcation as it facilitates the
hydrolysis of triglycerides to diglycerides and fatty acids. It
has been suggested (Dressman et al., 1998) that a suitable
surfactant be added to this media better simulate the surface
tensions typical of the fasted stomach. However, in vivo stud-
ies are worth being carried out to verify the performance of
this genuine system in a suitable animal model.4. Concluding remarks
This present study was designed to develop stable o/w
microemulsions comprising Miglyol 812 (medium chain,C6–C12, triglycerides), C8/C10 mono/diglycerides (Imwitor
988) and non-ionic surfactant polyoxyethylene-25-glyceryl
trioleate (Tagat TO). This type of formulation is referred to
as type II and is likely to retain its solvent capacity for the drug
after dispersion as it is comprised of water in-soluble compo-
nents. The resulting emulsions as assessed by particle size anal-
ysis are shown to be dependent on the glycerides blend
{Miglyol 812/Imwitor 988}, surfactant concentration, emulsiﬁ-
cation temperature and media. Manipulation of these param-
eters can result in emulsion formulations of controlled
droplet size and hence surface area. Such considerations are
important when the partition of lipophilic drugs into the aque-
ous phases and drug release rates are considered. Equilibrium
phase behavior studies have shown that the amount of water
solubilized as w/o (L2 phase) is of paramount importance for
the observed good emulsiﬁcation in these systems.Acknowledgments
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